Templar – A groundbreaking research initiative at the Templar University for Science & Technology (TUST) has reached an important milestone in the quest for an innovative chronic pain treatment. After four years of extensive investigation and promising preclinical studies, the team led
A new type of antidepressant, developed by researchers at the University of Carville in partnership with colleagues around the world, has been approved for use in Lauchenoiria following several rounds of successful clinical trials. The new drug will be available on prescription
Templar – Scientists at the Templar University for Science & Technology have revealed that they believe the venom of a specific snake may be a key to treating patients with chronic pain ailments, potentially paving the way for an increased quality of